Gregory Sullivan
2017
In 2017, Gregory Sullivan earned a total compensation of $383.4K as Chief Medical Officer at Tonix Pharmaceuticals Holding, a 8% decrease compared to previous year.
Compensation breakdown
| Option Awards | $48,443 |
|---|---|
| Salary | $335,000 |
| Total | $383,443 |
Sullivan received $335K in salary, accounting for 87% of the total pay in 2017.
Sullivan also received $48.4K in option awards.
Rankings
In 2017, Gregory Sullivan's compensation ranked 12,709th out of 14,666 executives tracked by ExecPay. In other words, Sullivan earned more than 13.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,709 out of 14,666 | 13th |
Division Manufacturing | 4,998 out of 5,772 | 13th |
Major group Chemicals And Allied Products | 1,833 out of 2,075 | 12th |
Industry group Drugs | 1,526 out of 1,731 | 12th |
Industry Pharmaceutical Preparations | 1,182 out of 1,333 | 11th |
Source: SEC filing on April 19, 2018.
Sullivan's colleagues
We found three more compensation records of executives who worked with Gregory Sullivan at Tonix Pharmaceuticals Holding in 2017.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019